MSA
OMCL icon

Marino Stram & Associates’s Omnicell OMCL Stock Holding History

Marino Stram & Associates’s Portfolio OMCL Stock Details OMCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-59
Closed -$5K – 417
2019
Q1 		$5K Buy
59
+5
+9% +$374 ﹤0.01% 380
2018
Q4 		$3K Buy
+54
New +$3.66K ﹤0.01% 427

Other funds holding OMCL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Marino Stram & Associates's OMCL Position: Q2 2019 in Review

Marino Stram & Associates sold out of Omnicell (OMCL) in Q2 2019, closing a stake of 59 shares — an estimated $5K sold.

Marino Stram & Associates first reported a position in OMCL in Q4 2018 and held it in 2 quarters. The position peaked at $5K in Q1 2019. 299 funds tracked by Wall St. Rank hold OMCL as of Q2 2019.

  • Marino Stram & Associates reported no remaining Omnicell position as of Q2 2019 after selling out during the quarter.
  • Marino Stram & Associates sold 59 Omnicell shares in Q2 2019, an estimated $5K.
  • Marino Stram & Associates first reported a position in Omnicell in Q4 2018 and held it in 2 quarters.
  • Marino Stram & Associates's Omnicell position peaked at $5K in Q1 2019.
  • 299 funds tracked by Wall St. Rank held Omnicell as of Q2 2019.

Based on Marino Stram & Associates's 13F filing for Q2 2019, filed 19 Jul 2019.